Samumed

Biosplice Therapeutics

Biosplice Therapeutics

American biopharmaceutical company

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman Kibar.[1]

Quick Facts Company type, Industry ...

Samumed's products in development target novel components of the Wnt signaling pathway.[2][3][4] The company focuses on potential treatments for several diseases; its osteoarthritis program is its most advanced.[3][5]

References

  1. [1]
    "Forbes Profile: Osman Kibar", "Forbes"
  2. [2]
    Herper, Matthew."Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging", "Forbes", May 10, 2016
  3. [3]
    Ramsey, Lydia. "A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles", "Business Insider", April 2, 2017
  4. [4]
    Lee, Yoolim. "Eternal Youth Is the Next Big Bet for Singapore Venture Capitalist", "Bloomberg", February 9, 2017
  5. [5]
    Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III", "Informa Scrip", November 8, 2017"


Stub icon

This corporation or company article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Samumed, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.